Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting.

about

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting.

Item

http://www.wikidata.org/entity/Q49437911

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@en

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@nl

type

Item

label

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@en

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@nl

prefLabel

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@en

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@nl

P1476

Antiemetic efficacy and safety ...... y-induced nausea and vomiting.

@en

P2093

Hiroyuki Watanabe

http://www.w3.org/2001/XMLSchema#string

Katsuto Takenaka

http://www.w3.org/2001/XMLSchema#string

Keiko Hosohata

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kamezaki

http://www.w3.org/2001/XMLSchema#string

Koichi Akashi

http://www.w3.org/2001/XMLSchema#string

Koji Kato

http://www.w3.org/2001/XMLSchema#string

Kojiro Hata

http://www.w3.org/2001/XMLSchema#string

Mayako Uchida

http://www.w3.org/2001/XMLSchema#string

Motoaki Shiratsuchi

http://www.w3.org/2001/XMLSchema#string

Toshihiro Miyamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia.

Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy.

Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis.

Antiemetic care for patients with breast cancer: focus on drug interactions and safety concerns.

Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens

Aprepitant: drug-drug interactions in perspective.

The role of serotonin and its receptors in activation of immune responses and inflammation.

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.

P2888

s40780-017-0097-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40780-017-0097-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsutomu Nakamura

P577

2018-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100269460

http://www.w3.org/2001/XMLSchema#string

P698

29345696

http://www.w3.org/2001/XMLSchema#string

P932

5761115

http://www.w3.org/2001/XMLSchema#string